Literature DB >> 31350597

Age-related Brain Metabolic Changes up to Seventh Decade in Healthy Humans : Whole-brain Magnetic Resonance Spectroscopic Imaging Study.

Helen Maghsudi1, Martin Schütze2, Andrew A Maudsley3, Mete Dadak2, Heinrich Lanfermann2, Xiao-Qi Ding2.   

Abstract

PURPOSE: To study brain metabolic changes under normal aging and to collect reference data for the study of neurodegenerative diseases.
METHODS: A total of 55 healthy subjects aged 20-70 years (n ≥ 5 per age decade for each gender) underwent whole-brain magnetic resonance spectroscopic imaging at 3T after completing a DemTect test and the Beck depressions inventory II to exclude cognitive impairment and mental disorder. Regional concentrations of N-acetylaspartate (NAA), choline-containing compounds (Cho), total creatine (tCr), glutamine and glutamate (Glx), and myo-inositol (mI) were determined in 12 brain regions of interest (ROIs). The two-sided t‑test was used to estimate gender differences and linear regression analysis was carried out to estimate age dependence of brain regional metabolite contents.
RESULTS: Brain regional metabolite concentrations changed with age in the majority of selected brain regions. The NAA decreased in 8 ROIs with a rate varying from -4.9% to -1.9% per decade, reflecting a general reduction of brain neuronal function or volume and density in older age; Cho increased in 4 ROIs with a rate varying from 4.3% to 6.1%; tCr and mI increased in one ROI (4.2% and 8.2% per decade, respectively), whereas Glx decreased in one ROI (-5.1% per decade), indicating an inhomogeneous increase of cell membrane turnover (Cho) with altered energy metabolism (tCr) and glutamatergic neuronal activity (Glx) as well as function of glia cell (mI) in normal aging brain.
CONCLUSION: Healthy aging up to the seventh decade of life is associated with regional dependent alterations of brain metabolism. These results provide a reference database for future studies of patients.

Entities:  

Keywords:  Healthy aging; Human brain metabolites; Whole-brain MR spectroscopic imaging

Mesh:

Substances:

Year:  2019        PMID: 31350597      PMCID: PMC7276177          DOI: 10.1007/s00062-019-00814-z

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  46 in total

1.  Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Authors:  Maxime Donadieu; Yann Le Fur; Angèle Lecocq; Andrew A Maudsley; Soraya Gherib; Elisabeth Soulier; Sylviane Confort-Gouny; Fanelly Pariollaud; Marie-Pierre Ranjeva; Jean Pelletier; Maxime Guye; Wafaa Zaaraoui; Bertrand Audoin; Jean-Philippe Ranjeva
Journal:  J Magn Reson Imaging       Date:  2016-01-12       Impact factor: 4.813

Review 2.  Creatine as a booster for human brain function. How might it work?

Authors:  Caroline D Rae; Stefan Bröer
Journal:  Neurochem Int       Date:  2015-08-18       Impact factor: 3.921

3.  A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations.

Authors:  J C Brooks; N Roberts; G J Kemp; M A Gosney; M Lye; G H Whitehouse
Journal:  Cereb Cortex       Date:  2001-07       Impact factor: 5.357

4.  Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy.

Authors:  M Harada; H Miyoshi; H Otsuka; H Nishitani; M Uno
Journal:  Neuroradiology       Date:  2001-06       Impact factor: 2.804

5.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

Authors:  P J Pouwels; J Frahm
Journal:  Magn Reson Med       Date:  1998-01       Impact factor: 4.668

Review 6.  Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.

Authors:  Timothy J Collier; Nicholas M Kanaan; Jeffrey H Kordower
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

7.  In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.

Authors:  Shao-Cheng Lin; Kun-Ju Lin; Ing-Tsung Hsiao; Chia-Ju Hsieh; Wey-Yil Lin; Chin-Song Lu; Shiaw-Pyng Wey; Tzu-Chen Yen; Mei-Ping Kung; Yi-Hsin Weng
Journal:  J Nucl Med       Date:  2013-11-28       Impact factor: 10.057

Review 8.  A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging.

Authors:  Kristin K Haga; Yuet Peng Khor; Andrew Farrall; Joanna M Wardlaw
Journal:  Neurobiol Aging       Date:  2007-08-23       Impact factor: 4.673

9.  MR-visible water content in human brain: a proton MRS study.

Authors:  P Christiansen; P B Toft; P Gideon; E R Danielsen; P Ring; O Henriksen
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

10.  Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.

Authors:  L L Chao; S G Mueller; S T Buckley; K Peek; S Raptentsetseng; J Elman; K Yaffe; B L Miller; J H Kramer; C Madison; D Mungas; N Schuff; M W Weiner
Journal:  Neurobiol Aging       Date:  2008-06-11       Impact factor: 4.673

View more
  2 in total

1.  Anti-inflammatory agent, OKN-007, reverses long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation.

Authors:  Rheal A Towner; Debra Saunders; Nataliya Smith; Rafal Gulej; Tyler McKenzie; Brandy Lawrence; Kathryn A Morton
Journal:  Geroscience       Date:  2019-09-02       Impact factor: 7.713

2.  Alterations of Striato-Thalamic Metabolism in Normal Aging Human Brain-An MR Metabolic Imaging Study.

Authors:  Mareike Ahlswede; Patrick Nösel; Andrew A Maudsley; Sulaiman Sheriff; Nima Mahmoudi; Paul Bronzlik; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Metabolites       Date:  2021-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.